Belkin Announces Mobile Charging Accessories That Are Made-to-Move and New Ways to Protect and Connect Devices
5.9.2024 10:00:00 CEST | Business Wire | Press release
Belkin International at Exhibit Hall 3.2, stand #210
Belkin, a leading consumer electronics brand for over 40 years, today announced 11 new travel-ready products across its mobile charging category, as well as solutions to enable more flexible options to work while on the go. Designed in California at its in-house labs, the new announcements underscore Belkin innovation, quality and its commitment to building products consumers need. All new products are made with post-consumer recycled (PCR) plastics in line with the company’s commitment to find more responsible ways to build products.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240905171274/en/
Belkin announces new BoostCharge collection at IFA 2024 (Photo: Business Wire)
Belkin International can be found on the IFA show floor, Exhibit Hall 3.2, stand #210.
Foldable Wireless Chargers with Qi2
BoostCharge Magnetic Foldable Charger
This folding stand design is compact and travel ready. Delivering 15W of fast wireless charging to iPhone and other Qi2 enabled devices, its powerful magnetic connection secures the device to charging stand and magnetically holds it vertically or horizontally for hands-free use. Use the elevated, customizable position to scroll or watch, and support the Standby Mode feature for iPhone users. It is available in two versions: standalone charges phone only; the 2-in-1 version charges phone and earbuds. 20W power supply and USB-C cable are included. Premium materials include soft touch phone pad, non-slip base and durable hinge construction.
Price: $44.99 / £39.99 / €44.99 to $69.99 / £59.99 / €69.99
Availability: Standalone version coming September 2024; 2-in-1 version available now at belkin.com and available from Autumn 2024 in select retailers worldwide.
BoostCharge 3-in-1 Magnetic Foldable Charger
Charge all your essentials with this foldable 3-in-1. Both portable and with customizable charging angles, it delivers 15W of fast wireless charging to iPhone or Qi2 enabled device, 5W to Apple Watch and 5W for earbuds. If used as a pad, keep it flat. If a stand is preferred, the pad lifts easily and holds steady. Simply fold it down for safe transport when it’s time to pack it away.
Price: $99.99 / £99.99 / €99.99
Availability: Available now at belkin.com and select retailers worldwide.
BoostCharge Pro Magnetic Wireless Travel Pad
A traveller’s best friend. Available in both 2-in-1 and 3-in-1 versions, use it as a pad or fold up into a stand. It delivers 15W of fast wireless charging to iPhone or Qi2 enabled device, 5W to Apple Watch and 5W for earbuds. Qi2 magnetic technology means the phone is held secure, optimizing energy usage and safeguarding the device's battery life.
Price: $119.00 / £109.00 / €119.00 to $129.99 / £119.99 / €129.99
Availability: Coming Autumn 2024 to belkin.com and select retailers worldwide.
High-capacityPower Banks
BoostCharge Power Bank 10K w/ Integrated Cable
This compact 10K power bank makes charging easy. With integrated PD PPS, charge a USB-C smartphone, earbuds or tablet. It provides the option to split the power and charge multiple devices at once. Available in Black, Blue and Pink and White (MEA exclusive).
Price: $39.99 / £24.99 / €29.99
Availability: Coming Autumn 2024 to belkin.com and select retailers worldwide.
BoostCharge Pro 3-Port Laptop Power Bank 20K
This 65W power bank is built with a 20K battery capacity; enough to charge a laptop, MacBook or smartphone quickly and safely. Its full colour digital display shows battery status to easily monitor the remaining charge and manage power needs efficiently for all devices. Options for 65W PD via single USB-C connection or split the power across two USB-Cs and a USB-A, to charge 3 devices simultaneously.
Price: $89.99 / £79.99 / €89.99
Availability: Available now at belkin.com and belkin.com/uk, and coming soon to select retailers worldwide.
Cables Made More Responsibly
BoostCharge 2-in-1 USB-C and Lightning Cable
Charge existing and future devices with this 2-in-1 cable. MFi and USB-IF certified and tested to over 30,000 bends and over 10,000 plug-ins, this cable will deliver up to 60W of power to any USB-C or Lightning device. It features a built-in interchangeable Lightning connector for users to easily switch between their charging needs. A handy cable strap keeps things tidy and protects it from tangles. Exterior braiding is made of 100% post-consumer recycled polyester, certified by the Global Recycled Standard (GRS), cable head and internal jacket are made of 50% GRS-certified post-consumer recycled thermoplastic.
This is part of a rolling change to transition all our PVC and Braided PVC to PCR material.
Price: $24.99 / £19.99 / €24.99
Availability: Coming Autumn 2024 to select retailers worldwide.
Portable Keyboards for Work-on-the-go
Pro Keyboard Case collection
The Belkin Pro Keyboard case makes working from anywhere, easy. The backlit Bluetooth keyboard pairs to iPad to offer the ease of use of an external keyboard with the added defence of a protective cover. The premium faux leather exterior protects the device, while a soft, anti-slip interior protects the screen from scratches. It auto wakes/sleeps when opening/closing, and features a large, click-anywhere trackpad. Its long-lasting battery (between 460mAh – 600mAh) holds charge independently from iPad.
- Everyday Keyboard Case with Cradle for iPad Air 10.9" and iPad Pro 11" £99.99/ €109.99
- Pro Keyboard Case with Magnetic Stand for iPad Air 10.9" and iPad Pro 11"£139.99 / €149.99
- Pro Keyboard Case with Magnetic Stand for iPad Pro 12.9"£189.99 / €199.99
Availability: Available now at belkin.com/uk,belkin.com/de and Belkin EMEA retailers.
Media kit is available for download HERE.
About Belkin
Belkin is a California-based accessories leader delivering award-winning power, protection, productivity, connectivity, and audio products over the last 40 years. Designed and engineered in Southern California and sold in more than 100 countries around the world, Belkin has maintained its steadfast focus on research and development, community, education, sustainability and most importantly, the people it serves. From our humble beginnings in a Southern California garage in 1983, Belkin has become a diverse, global technology company. We remain forever inspired by the planet we live on, and the connection between people and technology.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240905171274/en/
Contacts
For Media Inquiries:
For Media Inquiries:
Jen Wei
VP of Global Communications and Corporate Development
Comms@belkin.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 10:00:00 CEST | Press release
Analyses from the multinational MILOS study show that LDL-C reductions achieved with up to one year of treatment with bempedoic acid-containing therapies translate to a 17.1% relative reduction and a 4.8% absolute reduction in predicted 10-year cardiovascular risk.1 Real-world data demonstrated clinically relevant mean LDL-C reductions of at least 24.9%, regardless of patient gender or glycaemic status, after one year of follow-up.2,3 Findings presented at ESC Congress 2026 reinforce the clinical value of bempedoic acid in routine clinical practice, and demonstrate the continued investment of Daiichi Sankyo in addressing outstanding unmet needs in cardiovascular disease (CVD). Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom